SOPH
SOPHiA GENETICS SA
$4.85
-$0.17(-3.39%)
51
Overall
--
Value
60
Tech
42
Quality
Market Cap
$337.50M
Volume
69.09K
52W Range
$2.58 - $5.30
Target Price
$7.33
Company Overview
| Mkt Cap | $337.50M | Price | $4.85 |
| Volume | 69.09K | Change | -3.39% |
| P/E Ratio | -5.4 | Open | $5.07 |
| Revenue | $65.2M | Prev Close | $5.02 |
| Net Income | $-62.5M | 52W Range | $2.58 - $5.30 |
| Div Yield | N/A | Target | $7.33 |
| Overall | 51 | Value | -- |
| Quality | 42 | Technical | 60 |
No chart data available
About SOPHiA GENETICS SA
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is based in Rolle, Switzerland.
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Latest News
BTIG Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)
TipRanks Auto-Generated Intelligence Newsdesk•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SOPH | $4.85 | -3.4% | 69.09K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |